Arrowhead Pharmaceuticals Inc (ARWR)
Working Capital Ratio
65.72%
Quarterly · Period ending:
ARWR Working Capital Ratio
Latest reported65.72%period ending
Latest reported65.72%period ending
ARWR Quarterly Working Capital Ratio (-2700.00% → 65.72%)
Quarterly working capital ratio
High-resolution chart · PNG
ARWR working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 65.7224% | |
| 68.0931% | |
| 51.5505% | |
| 54.512% | |
| 54.4971% | |
| 58.1303% | |
| 47.0337% | |
| 51.9654% | |
| 39.9824% | |
| 49.8848% | |
| 27.8109% | |
| 41.0246% | |
| 50.2526% | |
| 54.7127% | |
| 42.6053% | |
| 34.3305% | |
| 40.4607% | |
| 39.6224% | |
| 31.5166% | |
| 33.5227% | |
| 44.9733% | |
| 55.4402% | |
| 59.814% | |
| 53.9114% | |
| 49.0257% | |
| 46.5429% | |
| 73.8458% | |
| 48.0716% | |
| 46.7454% | |
| 39.8748% | |
| 33.5356% | |
| 59.4962% | |
| 48.4867% | |
| 65.7774% | |
| 44.6502% | |
| 47.2993% | |
| 50.0365% | |
| 48.9773% | |
| 47.9919% | |
| 50.6011% | |
| 40.6404% | |
| 55.0539% | |
| 62.8076% | |
| 65.7534% | |
| 72.4258% | |
| 65.8564% | |
| 74.4229% | |
| 78.1951% | |
| 78.919% | |
| 74.7333% | |
| 72.7062% | |
| 53.8947% | |
| 66.8454% | |
| -27.5711% | |
| -0.0919% | |
| 7.4992% | |
| 0.5314% | |
| 12.161% | |
| 17.8381% | |
| 45.8142% | |
| 36.7864% | |
| 39.9459% | |
| 20.6625% | |
| 31.2074% | |
| 34.1573% | |
| 9.1624% | |
| 17.1822% | |
| 1.8088% | |
| -7.9895% | |
| -2.667% | |
| 27.0366% | |
| 39.6096% | |
| 62.6666% | |
| 73.5361% | |
| 78.0229% | |
| 75.0648% | |
| 79.4348% | |
| 79.3472% | |
| 80.8042% | |
| 74.8875% | |
| 72.9703% | |
| 74.3574% | |
| 69.7916% | |
| 75.0323% | |
| 80.3471% | |
| 62.6666% | |
| 69.463% | |
| 73.9136% | |
| 86.956% | |
| 99.5828% | |
| 98.9577% | |
| 93.522% | |
| -3,801.2751% | |
| -3,930.2135% | |
| -3,349.7675% | |
| -2,445.8693% | |
| -1,401.1039% | |
| -2,694.7499% | |
| -2,748.9055% | |
| -2,746.8308% |